88R HB 972
by Rep. Capriglione, different lead author · Died in committee · same text
Introduced textLast action, Mar 2, 2023: Referred to Public Health
Relating to warning labels for opioid prescription drugs.
Caption, 88R bill history
SB 449
Filed
Initial review · graded Nov 19, 2026 · How we grade
relating to warning labels for opioid prescription drugs.
Caption from analyzed text · version I.
Addiction, breathing problems, overdose. Pharmacists add the label starting March 1, 2028.
The bill requires pharmacists to put a warning label on every opioid bottle or container that warns of addiction, breathing problems and overdose. It touches pharmacists and the Texas State Board of Pharmacy, which must write the label rules by January 1, 2028. Starting March 1, 2028, a pharmacist may not dispense an opioid without the label reading something close to "CAUTION: Opioid. Risk of Addiction, Respiratory Depression, and Overdose."
Labels: ZOMBIE BILL. Died 2 times: 88R HB 972 by Rep. Capriglione (Died in committee) and 89R SB 1986 (Did not pass). Checked against 88R and 89R only.BACK FROM THE DEAD. Same text as a bill filed before that died: 88R HB 972 by Rep. Capriglione (Died in committee) and 89R SB 1986 (Did not pass). Filed in 3 sessions, counting this one. Checked against 88R and 89R only.TRY NO. 3. Filed in 3 sessions: 88R, 89R and 90R. Checked against 88R and 89R only.
90R-SB449 · 2026-11-19
relating to warning labels for opioid prescription drugs.
Addiction, breathing problems, overdose. Pharmacists add the label starting March 1, 2028.
The bill requires pharmacists to put a warning label on every opioid bottle or container that warns of addiction, breathing problems and overdose. It touches pharmacists and the Texas State Board of Pharmacy, which must write the label rules by January 1, 2028. Starting March 1, 2028, a pharmacist may not dispense an opioid without the label reading something close to "CAUTION: Opioid. Risk of Addiction, Respiratory Depression, and Overdose."
[ ] NONE FOUND
No fiscal note in the loaded record.
2026-11-19 Filed (per the TLO filing feed)
No verified beat found.
THANK YOU FOR CHECKING THE RECEIPT
CAMPAIGN PAID FOR BY
Not tied to this bill.
The author's campaign account only. Own money and internal transfers are separate on the member page.
Derived itemized flow · Jul 1, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
$135,000.00
Also funds 124 other sitting lawmakers.
Derived recipient stock · Jul 10, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamDerived itemized flow · Sep 12, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100987789, 101010195, 101040645, 101069307, 101073278.
$116,000.00
Also funds 30 other sitting lawmakers.
Derived recipient stock · Sep 3, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamDerived itemized flow · Jun 27, 2025 to Oct 5, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 101010195, 101033131, 101073278.
$100,000.00
Also funds 0 other sitting lawmakers.
Derived recipient stock · Sep 29, 2026 to Oct 5, 2026. State data as of Nov 4, 2026.
Name match, not a verified identity: normalized filed name and state.
Derived itemized flow · Sep 29, 2026 to Oct 5, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 101073278.
Missing data does not establish zero giving. Display amounts are rounded.
$135,000.00
Also funds 124 other sitting lawmakers.
Derived recipient stock · Jul 10, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamDerived itemized flow · Sep 12, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100987789, 101010195, 101040645, 101069307, 101073278.
$116,000.00
Also funds 30 other sitting lawmakers.
Derived recipient stock · Sep 3, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamDerived itemized flow · Jun 27, 2025 to Oct 5, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 101010195, 101033131, 101073278.
$100,000.00
Also funds 0 other sitting lawmakers.
Derived recipient stock · Sep 29, 2026 to Oct 5, 2026. State data as of Nov 4, 2026.
Name match, not a verified identity: normalized filed name and state.
Derived itemized flow · Sep 29, 2026 to Oct 5, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 101073278.
No floor vote loaded for this bill.
No fiscal note in the loaded record.
Analysis of text version I by a super-expensive superintelligence, Nov 19, 2026, against the published rubric.
Filed 3 times: 88R, 89R and now. Checked against 88R and 89R only.
by Rep. Capriglione, different lead author · Died in committee · same text
Introduced textLast action, Mar 2, 2023: Referred to Public Health
Relating to warning labels for opioid prescription drugs.
Caption, 88R bill history
by Sen. Hall, same lead author · Did not pass · same text
Introduced textLast action, May 26, 2025: Placed on General State Calendar
Relating to warning labels for opioid prescription drugs.
Caption, 89R bill history
Texas Senate · Filed Nov 19, 2026
2026-11-19 Filed (per the TLO filing feed)
Texas Legislature Online · Introduced text: HTML · PDF
Data snapshot Nov 19, 2026 at 5:07 PM CST. Grades, charges, quotes and corrections follow the published record.
The text as introduced · 499 words
90R675 RDR-D By: Hall S.B. No. 449 A BILL TO BE ENTITLED AN ACT relating to warning labels for opioid prescription drugs. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Section 481.074(a), Health and Safety Code, is amended to read as follows: (a) A pharmacist may not: (1) dispense or deliver a controlled substance or cause a controlled substance to be dispensed or delivered under the pharmacist's direction or supervision except under a valid prescription and in the course of professional practice; (2) dispense a controlled substance if the pharmacist knows or should have known that the prescription was issued without a valid patient-practitioner relationship; (3) fill a prescription that is not prepared or issued as prescribed by this chapter; (4) permit or allow a person who is not a licensed pharmacist or pharmacist intern to dispense, distribute, or in any other manner deliver a controlled substance even if under the supervision of a pharmacist, except that after the pharmacist or pharmacist intern has fulfilled his professional and legal responsibilities, a nonpharmacist may complete the actual cash or credit transaction and delivery; [ or ] (5) permit the delivery of a controlled substance to any person not known to the pharmacist, the pharmacist intern, or the person authorized by the pharmacist to deliver the controlled substance without first requiring identification of the person taking possession of the controlled substance, except as provided by Subsection (n) ; or (6) dispense an opioid unless the bottle or container in which the opioid is dispensed is affixed with a label warning of the addictive nature of opioids and the risks of respiratory depression and overdose as required by board rule under Section 481.0761(l) . SECTION 2. Section 481.0761, Health and Safety Code, is amended by adding Subsection (l) to read as follows: (l) The board shall adopt rules requiring that an opioid be dispensed in a bottle or container affixed with a label warning users of the addictive nature of opioids and the risks of respiratory depression and overdose. The label must include language substantially similar to the following: "CAUTION: Opioid. Risk of Addiction, Respiratory Depression, and Overdose." SECTION 3. The Texas State Board of Pharmacy shall adopt the rules required under Section 481.0761(l), Health and Safety Code, as added by this Act, not later than January 1, 2028. SECTION 4. The change in law made by this Act applies only to a prescription for an opioid dispensed on or after March 1, 2028. A prescription dispensed before March 1, 2028, is governed by the law in effect immediately before the effective date of this Act, and the former law is continued in effect for that purpose. SECTION 5. This Act takes effect immediately if it receives a vote of two-thirds of all the members elected to each house, as provided by Section 39, Article III, Texas Constitution. If this Act does not receive the vote necessary for immediate effect, this Act takes effect September 1, 2027.
Comments
Reader comments, text only. New comments show a generated Texas name. Links, threats and private details wait for the editor, and slurs and spam are turned away. Nothing is screened for opinion. How comments work.
Loading comments.